Dian Swastatika Sentosa Tbk vs Merck Tbk. — how do they compare? Dian Swastatika Sentosa Tbk trades at Rp800 (market cap 154.11T, 159.4M 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Dian Swastatika Sentosa Tbk is far larger — about 91.7× Merck Tbk.'s market cap, and Dian Swastatika Sentosa Tbk is more actively traded (159.4M versus 33.3K). Which is the better fit depends on your goals.
| DSSA | MERK | |
|---|---|---|
Market Cap | 154.11T | 1.68T |
Volume | 159.4M | 33.3K |
Lot | 1.59M | 333 |
Turnover | 128.84B | 126.46M |
Average Price | 808.29 | 3,797.72 |
Value | 128.84B | 126.46M |
Indicative Equilibrium Price | 800 | 3,800 |
Indicative Equilibrium Volume | 60.24K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Dian Swastatika Sentosa Tbk (the company) was established on August 2, 1996 based on Notarial Deed No. 6 and was amended by Notarial Deed No. 35 dated October 8, 1996, both of Linda Herawati, S.H., a public notary in Jakarta. The Company operates under the Sinarmas group of business.
Read more on DSSA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →